Clinical Scores, Biomarkers, and CT Findings in Acute Pulmonary Embolism
ConditionAcute Pulmonary Embolism
Trial statusNot yet recruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age18+
SponsorSohag University
About this trial
This study aims to compare clinical scoring systems, laboratory biomarkers, and computed tomography (CT) findings in patients diagnosed with acute pulmonary embolism in different hospital departments.
The study will include patients diagnosed with acute pulmonary embolism at Sohag University Hospital. Clinical data, laboratory results, and imaging findings will be collected and analyzed to evaluate their diagnostic and prognostic value.
The goal of this research is to identify the most reliable and practical tools for early diagnosis and risk stratification of acute pulmonary embolism, which may help improve patient management and outcomes.
This is an observational study and does not involve any intervention or change in standard patient care.
Eligibility criteria
This trial does not accept healthy volunteersQualifiers
• Adults aged ≥ 18 years
Confirmed acute pulmonary embolism by CTPA
Disqualifiers
• Chronic pulmonary embolism
Non-diagnostic CTPA
Refusal to participate
Severe renal impairment precluding contrast-enhanced CT
Trial population
Adult patients with confirmed acute pulmonary embolism admitted to Sohag University Hospital from different departments including Emergency, ICU, Medical, and Surgical wards.
Trial design
Design model
Cohort
Time perspective
Prospective
Treatments tested in this trial
No Intervention (Observational Study Data Collection)
Other interventionThis is an observational study with no active intervention. All data are collected from routine clinical care, including clinical scoring systems, laboratory biomarkers, and computed tomography pulmonary angiography (CTPA) findings in patients with acute pulmonary embolism.
Treatment groups
50 Participants
are divided into 1 treatment groupGroup A: Acute Pulmonary Embolism Group1 intervention
Trial outcomes
Primary outcomes
1
Number of Participants with In-Hospital All-Cause Mortality
All-cause mortality among adult patients with confirmed acute pulmonary embolism, defined as death from any cause occurring during hospitalization. The outcome will be assessed as the number of participants who die before hospital discharge.
Time frame
Up to 30 daysLocations
Sponsors and contacts
Click on the lead sponsor to view all of their trials.
Source ClinicalTrials.gov
This trial is not recruiting at the moment. You can still explore other options: